EXPERT PROFILE
Strategic Leadership.
Niklas Anzinger is Founder and CEO of Infinita and General Partner at Infinita VC, where he works at the intersection of biotechnology, regulation, and innovation policy. His work focuses on creating new environments that accelerate the translation of promising therapies from early scientific evidence to patient access.
Through collaborations with policymakers, treatment developers, clinicians, and research organizations, Niklas has helped develop and expand emerging clinical access pathways, including initiatives in Próspera and the United States.
His experience spans pathway design, regulatory strategy, ecosystem development, and commercialization, providing biotechnology teams with practical guidance on navigating novel clinical access opportunities.
